Infectious Disease News Current Issue
The following articles appeared in the print edition of Infectious Disease News.
Table of Contents
- Human Microbiome Project may hold promise for future
-
- CDC renews recommendation for hormonal contraception use in women with HIV
- Contaminated surfaces lead to first human case of laboratory-acquired cowpox virus
- Drotrecogin alfa (activated) improved mortality rates in severe sepsis
- FDA approves Truvada for PrEP
- Government often pays twice for veterans in federal health plans
- H1N1 vaccination reduced influenza related hospital admissions in Scotland
- H1N1 vaccine given to pregnant women not linked to poor birth outcomes
- Herpes zoster incidence did not increase among those who received the vaccine
-
- High blood sugar levels identified patients at risk for death from pneumonia
- Higher HIV RNA levels associated with elevated inflammation biomarkers
- HIV drug reduces GVHD in bone marrow transplant patients
- Incidence of MRSA decreased from 2005-2010
- Indoor residual spraying effectively reduced malaria prevalence
- Milk thistle showed no benefit in HCV
- Once-daily doxycycline noninferior to twice-daily capsule for chlamydia
- Rate of death linked to H1N1 15 times higher than previously confirmed
-
- Risk for HIV acquisition with HIV vaccine confirmed on follow-up
- Tenofovir gel did not compromise vaginal mucosa barrier
- Unexplained respiratory disease outbreaks common in US
- Vaginal discharge unreliable predictor of STI
- AIDS 2012: Another major step in war against HIV epidemic Paul A. Volberding, MD
- Chlamydia rates continue to rise: What we are doing wrong Toni Darville, MD
- Efavirenz-based regimen in children with TB/HIV appears beneficial
- HIV testing rates increased among young MSM
-
- Leaders call for more research to achieve goal of AIDS-free generation
- New statin shows little interaction with protease inhibitor combination in HIV
- Racial disparities observed with HIV transmission potential of MSM
- Structural factors present major challenges for reducing HIV burden in MSM